Authors' Reply to Moura Et Al.: "Safety of Janus Kinase Inhibitors in Older Patients: A Focus on the Thromboembolic Risk"

Overview

Journal Drugs Aging

Specialties Geriatrics
Pharmacology

Date 2021 Apr 19

PMID 33871805

Authors

Suraj Rajasimhan

Omer Pamuk

James D Katz

Affiliations

Soon will be listed here.

References

Moura C, Rosa F, Assis L, Moura C . Comment on "Safety of Janus Kinase Inhibitors in Older Patients: A Focus on the Thromboembolic Risk". Drugs Aging. 2021; 38(6):535-537. DOI: 10.1007/s40266-021-00857-3. View

Rajasimhan S, Pamuk O, Katz J . Safety of Janus Kinase Inhibitors in Older Patients: A Focus on the Thromboembolic Risk. Drugs Aging. 2020; 37(8):551-558. PMC: 7387323. DOI: 10.1007/s40266-020-00775-w. View

Gimenez Poderos T, Gallardo Borge S, Vazquez-Ferreiro P . Risk of Venous Thromboembolism Associated With Tofacitinib and Baricitinib: A Systematic Review and Indirect Meta-Analysis. Pharmacotherapy. 2020; 40(12):1248-1264. DOI: 10.1002/phar.2472. View

Mohamed M, Beck D, Camp H, Othman A . Preferential Inhibition of JAK1 Relative to JAK3 by Upadacitinib: Exposure-Response Analyses of Ex Vivo Data From 2 Phase 1 Clinical Trials and Comparison to Tofacitinib. J Clin Pharmacol. 2019; 60(2):188-197. PMC: 6973126. DOI: 10.1002/jcph.1513. View

Zhang X, Chua L, Ernest 2nd C, Macias W, Rooney T, Tham L . Dose/Exposure-Response Modeling to Support Dosing Recommendation for Phase III Development of Baricitinib in Patients with Rheumatoid Arthritis. CPT Pharmacometrics Syst Pharmacol. 2017; 6(12):804-813. PMC: 5744177. DOI: 10.1002/psp4.12251. View

Vallejo-Yague E, Weiler S, Micheroli R, Burden A . Thromboembolic Safety Reporting of Tofacitinib and Baricitinib: An Analysis of the WHO VigiBase. Drug Saf. 2020; 43(9):881-891. DOI: 10.1007/s40264-020-00958-9. View

Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman P, Mar B . Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014; 371(26):2488-98. PMC: 4306669. DOI: 10.1056/NEJMoa1408617. View

Steensma D, Bejar R, Jaiswal S, Lindsley R, Sekeres M, Hasserjian R . Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015; 126(1):9-16. PMC: 4624443. DOI: 10.1182/blood-2015-03-631747. View

Savola P, Lundgren S, Keranen M, Almusa H, Ellonen P, Leirisalo-Repo M . Clonal hematopoiesis in patients with rheumatoid arthritis. Blood Cancer J. 2018; 8(8):69. PMC: 6066480. DOI: 10.1038/s41408-018-0107-2. View

10.

Veninga A, de Simone I, Heemskerk J, Ten Cate H, van der Meijden P . Clonal hematopoietic mutations linked to platelet traits and the risk of thrombosis or bleeding. Haematologica. 2020; 105(8):2020-2031. PMC: 7395290. DOI: 10.3324/haematol.2019.235994. View

11.

Kotyla P, Engelmann M, Giemza-Stoklosa J, Wnuk B, Islam M . Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?. Int J Mol Sci. 2021; 22(5). PMC: 7957632. DOI: 10.3390/ijms22052449. View

12.

Smolen J, Genovese M, Takeuchi T, Hyslop D, Macias W, Rooney T . Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment. J Rheumatol. 2018; 46(1):7-18. DOI: 10.3899/jrheum.171361. View

13.

Ng A, Kauppi M, Metcalf D, Hyland C, Josefsson E, Lebois M . Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation. Proc Natl Acad Sci U S A. 2014; 111(16):5884-9. PMC: 4000844. DOI: 10.1073/pnas.1404354111. View

14.

Meyer S, Keller M, Woods B, LaFave L, Bastian L, Kleppe M . Genetic studies reveal an unexpected negative regulatory role for Jak2 in thrombopoiesis. Blood. 2014; 124(14):2280-4. PMC: 4183987. DOI: 10.1182/blood-2014-03-560441. View

15.

Dorner T, Tanaka Y, Petri M, Smolen J, Wallace D, Dow E . Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Lupus Sci Med. 2020; 7(1). PMC: 7549481. DOI: 10.1136/lupus-2020-000424. View